Microbiome-mediated incapacitation of interferon lambda production in the oral mucosa
暂无分享,去创建一个
Maxim N. Artyomov | R. Lamont | M. Artyomov | Melissa A. Metzler | J. Bagaitkar | Daniel P. Miller | K. Sokoloski | Konstantin Zaitsev | C. J. Rodriguez-Hernandez | Kendall Stocke | Shunying Jin | Daonan Shen | H. Dukka | B. Shpak | Kendall S Stocke
[1] G. Borisy,et al. Spatial scale in analysis of the dental plaque microbiome. , 2021, Periodontology 2000.
[2] M. Duncan,et al. A simple method for quantitating confocal fluorescent images , 2021, Biochemistry and biophysics reports.
[3] R. Marsault,et al. Detection of Epstein–Barr Virus in Periodontitis: A Review of Methodological Approaches , 2020, Microorganisms.
[4] S. Janković,et al. Detection rates of periodontal bacteria and herpesviruses in different forms of periodontal disease , 2020, Microbiology and immunology.
[5] P. Staeheli,et al. Interferon-λ Receptor Expression: Novel Reporter Mouse Reveals Within- and Cross-Tissue Heterogeneity. , 2020, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[6] L. Prokunina-Olsson,et al. COVID-19 and emerging viral infections: The case for interferon lambda , 2020, The Journal of experimental medicine.
[7] P. Feng,et al. Herpesvirus-bacteria synergistic interaction in periodontitis. , 2019, Periodontology 2000.
[8] C. Wilen,et al. The intestinal regionalization of acute norovirus infection is regulated by the microbiota via bile acid-mediated priming of type III interferon , 2019, Nature Microbiology.
[9] R. Plemper,et al. Segmented Filamentous Bacteria Prevent and Cure Rotavirus Infection , 2019, Cell.
[10] Ebrahim Hassan,et al. Norovirus encounters in the gut: multifaceted interactions and disease outcomes , 2019, Mucosal Immunology.
[11] S. Anderson,et al. Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and III Interferons. , 2019, Immunity.
[12] M. Morita,et al. Characteristics of the Salivary Microbiota in Patients With Various Digestive Tract Cancers , 2019, Front. Microbiol..
[13] M. Baldridge,et al. Interactions between noroviruses, the host, and the microbiota. , 2019, Current opinion in virology.
[14] Wen-Tao Ma,et al. The Commensal Microbiota and Viral Infection: A Comprehensive Review , 2019, Front. Immunol..
[15] P. Staeheli,et al. Interferon-λ orchestrates innate and adaptive mucosal immune responses , 2019, Nature Reviews Immunology.
[16] S. Kotenko,et al. Type III IFNs: Beyond antiviral protection. , 2019, Seminars in immunology.
[17] M. Diamond,et al. Shared and Distinct Functions of Type I and Type III Interferons. , 2019, Immunity.
[18] C. Jefferies. Regulating IRFs in IFN Driven Disease , 2019, Front. Immunol..
[19] P. Sethupathy,et al. Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses , 2019, Nature Microbiology.
[20] Kyudong Han,et al. Amelogenic transcriptome profiling in ameloblast-like cells derived from adult gingival epithelial cells , 2019, Scientific Reports.
[21] Meagan E. Sullender,et al. Viral complementation of immunodeficiency confers protection against enteric pathogens via IFN-λ , 2019, Nature Microbiology.
[22] M. Diamond,et al. Interferon lambda protects the female reproductive tract against Zika virus infection , 2019, Nature Communications.
[23] A. García-Sastre,et al. ISRE-Reporter Mouse Reveals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes , 2018, Cell reports.
[24] C. Coyne,et al. Type III Interferons in Antiviral Defenses at Barrier Surfaces. , 2018, Trends in immunology.
[25] A. Naqvi,et al. Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease? , 2018, Front. Immunol..
[26] R. Lamont,et al. Maturation of the Mfa1 Fimbriae in the Oral Pathogen Porphyromonas gingivalis , 2018, Front. Cell. Infect. Microbiol..
[27] Christian Eggeling,et al. Infection with a Brazilian isolate of Zika virus generates RIG‐I stimulatory RNA and the viral NS5 protein blocks type I IFN induction and signaling , 2018, European journal of immunology.
[28] Larissa B. Thackray,et al. Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections , 2018, Cell reports.
[29] D. Di Nardo,et al. In vitro resistance to fracture of two nickel-titanium rotary instruments made with different thermal treatments. , 2017, Annali di stomatologia.
[30] R. Lamont,et al. Genes Contributing to Porphyromonas gingivalis Fitness in Abscess and Epithelial Cell Colonization Environments , 2017, Front. Cell. Infect. Microbiol..
[31] F. Granucci,et al. IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function , 2017, Nature Immunology.
[32] T. Morrison,et al. Identification of Interactions between Sindbis Virus Capsid Protein and Cytoplasmic vRNA as Novel Virulence Determinants , 2017, PLoS pathogens.
[33] S. Kotenko,et al. Interferon‐&lgr; Mediates Non‐redundant Front‐Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness , 2017, Immunity.
[34] R. Garofalo,et al. Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition , 2017, Nature Microbiology.
[35] C. Genco,et al. Microbial Degradation of Cellular Kinases Impairs Innate Immune Signaling and Paracrine TNFα Responses , 2016, Scientific Reports.
[36] Adolfo García-Sastre,et al. Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. , 2016, Cell host & microbe.
[37] R. Lamont,et al. Porphyromonas gingivalis initiates a mesenchymal‐like transition through ZEB1 in gingival epithelial cells , 2016, Cellular microbiology.
[38] K. Pyrć,et al. Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis , 2015, Journal of Innate Immunity.
[39] Tamotsu Kato,et al. Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver , 2015, PloS one.
[40] M. Katze,et al. Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression. , 2015, Cell host & microbe.
[41] M. Kimmel,et al. NF-κB and IRF pathways: cross-regulation on target genes promoter level , 2015, BMC Genomics.
[42] R. Lamont,et al. Polymicrobial synergy and dysbiosis in inflammatory disease. , 2015, Trends in molecular medicine.
[43] M. Diamond,et al. Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection , 2015, Science.
[44] T. Hassanein,et al. A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection. , 2014, Journal of hepatology.
[45] A. García-Sastre,et al. The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. , 2014, Cell host & microbe.
[46] V. Hornung,et al. OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids , 2014, Nature Reviews Immunology.
[47] P. Cossart,et al. Diverse intracellular pathogens activate Type III Interferon expression from peroxisomes , 2014, Nature Immunology.
[48] R. Lamont,et al. Establishment and characterization of a telomerase immortalized human gingival epithelial cell line. , 2013, Journal of periodontal research.
[49] P. Stafford,et al. Gingipain-dependent degradation of mammalian target of rapamycin pathway proteins by the periodontal pathogen Porphyromonas gingivalis during invasion. , 2013, Molecular oral microbiology.
[50] Orland R. Gonzalez,et al. A Systematic Analysis of Host Factors Reveals a Med23-Interferon-λ Regulatory Axis against Herpes Simplex Virus Type 1 Replication , 2013, PLoS pathogens.
[51] R. Lamont,et al. The Serine Phosphatase SerB of Porphyromonas gingivalis Suppresses IL-8 Production by Dephosphorylation of NF-κB RelA/p65 , 2013, PLoS pathogens.
[52] G. Gallagher,et al. Regulation of IFN-λ1 Promoter Activity (IFN-λ1/IL-29) in Human Airway Epithelial Cells , 2011, The Journal of Immunology.
[53] John D Lambris,et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. , 2011, Cell host & microbe.
[54] M. Hornef,et al. IFN-λ determines the intestinal epithelial antiviral host defense , 2011, Proceedings of the National Academy of Sciences.
[55] S. Akira,et al. Pattern Recognition Receptors and Inflammation , 2010, Cell.
[56] Ryan M. O’Connell,et al. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. , 2009, Cell host & microbe.
[57] F. Nunes,et al. Detection of herpesviruses and periodontal pathogens in subgingival plaque of patients with chronic periodontitis, generalized aggressive periodontitis, or gingivitis. , 2008, Journal of periodontology.
[58] F. Nunes,et al. Detection of Epstein-Barr virus and human cytomegalovirus in blood and oral samples: comparison of three sampling methods. , 2008, Journal of oral science.
[59] K. Honda,et al. Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors , 2006 .
[60] J. Slots,et al. Herpes viruses and periodontopathic bacteria in early-onset periodontitis. , 2001, Journal of clinical periodontology.
[61] G. Taylor,et al. Aspiration Pneumonia: Dental and Oral Risk Factors in an Older Veteran Population , 2001, Journal of the American Geriatrics Society.
[62] S. Socransky,et al. Comparison of the microbiota of supra- and subgingival plaque in health and periodontitis. , 2000, Journal of clinical periodontology.
[63] J. Slots,et al. Herpesviruses in periodontal pocket and gingival tissue specimens. , 2000, Oral microbiology and immunology.
[64] J. Slots,et al. Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria. , 1999, Journal of periodontology.
[65] L. Christersson,et al. Subgingival distribution of periodontal pathogenic microorganisms in adult periodontitis. , 1992, Journal of periodontology.